Concomitant prescription of psychotropic and cardiovascular drugs in elderly patients

References

• Atkin PA, Veitch PC, Veitch EM, et al. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging. 1999;14:141–152. doi: 10.2165/00002512-199914020-00005
   PubMed Web of Science ®Google Scholar
• Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J. 2001;31:199–205. doi: 10.1046/j.1445-5994.2001.00044.x
   PubMed Web of Science ®Google Scholar
• Jörgensen T, Johansson S, Kennerfalk A, et al. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother. 2001;35:1004–1009. doi: 10.1345/aph.10351
   PubMed Web of Science ®Google Scholar
• Roughead EE, Barratt JD, Gilbert AL. Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf. 2004;13:83–87. doi: 10.1002/pds.912
   Web of Science ®Google Scholar
• Enger C, Weatherby L, Reynolds RF, et al. Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis. 2004;192:19–27. doi: 10.1097/01.nmd.0000105996.62105.07
   PubMed Web of Science ®Google Scholar
• Frasure-Smith N, Lespérance F. Recent evidence linking coronary heart disease and depression. Can J Psychiatry. 2006;51:730–737. doi: 10.1177/070674370605101202
   PubMed Web of Science ®Google Scholar
• Gonzalez MB, Snyderman TB, Colket JT, et al. Depression in patients with coronary artery disease. Depression. 1996;4:57–62. doi: 10.1002/(SICI)1522-7162(1996)4:2<57::AID-DEPR3>3.0.CO;2-C
   PubMedGoogle Scholar
• Brown TM, Stoudemire A. Psychiatric side effects of prescription and over-the-counter medications. Recognition and management. Washington (DC): American Psychiatric Publishing; 1998. p. 27–42.
   Google Scholar
• Schleifer SJ, Slater WR, Macari-Hinson MM, et al. Digitalis and beta-blocking agents: effects on depression following myocardial infarction. Am Heart J. 1991;121:1397–1402. doi: 10.1016/0002-8703(91)90144-7
   PubMed Web of Science ®Google Scholar
• Rodriguez de la Torre B, Dreher J, Malevany I, et al. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients. Ther Drug Monit. 2001;23:435–440. doi: 10.1097/00007691-200108000-00019
   PubMed Web of Science ®Google Scholar
• Shah SU, Iqbal Z, White A, et al. Heart and mind: (2) Psychotropic and cardiovascular therapeutics. Postgrad Med J. 2005;81:33–40. doi: 10.1136/pgmj.2003.015230
   Web of Science ®Google Scholar
• Juurlink DN, Mamdani MM, Kopp A, et al. Drug-induced lithium toxicity in the elderly: a population-based study. J Am Geriatr Soc. 2004;52:794–798. doi: 10.1111/j.1532-5415.2004.52221.x
   PubMed Web of Science ®Google Scholar
• Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289:1652–1658. doi: 10.1001/jama.289.13.1652
   PubMed Web of Science ®Google Scholar
• Elliot RA. Problems with medication use in the elderly: an Australian perspective. J Pharm Pract Res. 2006;36:58–66. doi: 10.1002/j.2055-2335.2006.tb00889.x
   Google Scholar
• Chaplin S. Polypharmacy: tackling the reality of multiple morbidities. Prescriber. 2014;25:26–28. doi: 10.1002/psb.1168
   Google Scholar
• Linjakumpu T, Hartikainen S, Klaukka T, et al. Psychotropics among the home-dwelling elderly – increasing trends. Int J Geriatr Psychiatry. 2002;17:874–883. doi: 10.1002/gps.712
   PubMed Web of Science ®Google Scholar
• Hartikainen S, Klaukka T. Use of psychotropics is high among very old people. Eur J Clin Pharmacol. 2004;59:849–850. doi: 10.1007/s00228-003-0702-3
   Web of Science ®Google Scholar
• Kawachi I, Sparrow D, Vokonas PS, et al. Symptoms of anxiety and risk of coronary heart disease: the normative aging study. Circulation. 1994;90:2225–2229. doi: 10.1161/01.CIR.90.5.2225
   PubMed Web of Science ®Google Scholar
• Kubzansky LD, Kawachi I, Spiro A, et al. Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the normative aging study. Circulation. 1997;95:818–824. doi: 10.1161/01.CIR.95.4.818
   PubMed Web of Science ®Google Scholar
• Chen YF, Dewey ME, Avery AJ, Analysis Group of the MRCCFA Study. The Medical Research Council Cognitive Function and Ageing Study (MRC CFAS), self-reported medication use for older people in England and wales. J Clin Pharm Ther. 2001;26:129–140. doi: 10.1046/j.1365-2710.2001.00333.x
   PubMed Web of Science ®Google Scholar
• Brekke M, Hunskaar S, Straand J. Antihypertensive and lipid lowering treatment in 70–74 year old individuals – predictors for treatment and blood-pressure control: a population based survey. The Hordaland Health Study (HUSK). BMC Geriatr. 2006;6:1601. doi: 10.1186/1471-2318-6-16
   Google Scholar
• Putnam W, Burge FI, Lawson B, et al. Evidence-based cardiovascular care in the community: a population based cross-sectional study. BMC Fam Pract. 2004;5:6. doi: 10.1186/1471-2296-5-6
   Google Scholar
• Strandberg TE, Pitkälä K, Kulp S, et al. Use of cardiovascular drugs by home-dwelling coronary patients aged 75 years and older. A population-based cross-sectional survey in Helsinki, Finland. Eur J Clin Pharmacol. 2001;57:513–516. doi: 10.1007/s002280100311
   Web of Science ®Google Scholar
• Lahoz C, Mantilla T, Taboada M, et al. Gender differences in evidence-based pharmacological therapy for patients with stable coronary heart disease. Int J Cardiol. 2009;133:336–340. doi: 10.1016/j.ijcard.2007.12.115
   Web of Science ®Google Scholar
• Koopman C, Vaartjes I, Heintjes EM, et al. Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998–2010. Eur Heart J. 2013;34:3198–3205. doi: 10.1093/eurheartj/eht368
   PubMed Web of Science ®Google Scholar
• Lee HY, Cooke CE, Robertson TA. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. J Manag Care Pharm. 2008;14:271–280.
   PubMed Web of Science ®Google Scholar
• Faulx MD, Francis GS. Adverse drug reactions in patients with cardiovascular disease. Curr Probl Cardiol. 2008;33:703–768. doi: 10.1016/j.cpcardiol.2008.08.002
   PubMed Web of Science ®Google Scholar
• Movig KLL, Leufkens HGM, Lenderink AW, et al. Association between antidepressant drug use and hyponatraemia: a case-control study. Br J Clin Pharmacol. 2002;53:363–369. doi: 10.1046/j.1365-2125.2002.01550.x
   PubMed Web of Science ®Google Scholar
• Tatley M, Savage R. Psychiatric adverse reactions with statins, fibrates and ezetimibe: implications for the use of lipid lowering agents. Drug Saf. 2007;30:195–201. doi: 10.2165/00002018-200730030-00003
   PubMed Web of Science ®Google Scholar
• Morales K, Wittink M, Datto C, et al. Simvastatin causes changes in affective processes in elderly volunteers. J Am Geriatr Soc. 2006;54:70–76. doi: 10.1111/j.1532-5415.2005.00542.x
   PubMed Web of Science ®Google Scholar
• Callréus T, Agerskov Andersen U, Hallas J, et al. Cardiovascular drugs and the risk of suicide: a nested case-control study. Eur J Clin Pharmacol. 2007;63:591–596. doi: 10.1007/s00228-007-0293-5
   PubMed Web of Science ®Google Scholar
• Köhler O, Gasse C, Petersen L, et al. The effect of concomitant treatment With SSRIs and statins: A population-based study. Am J Psychiatry. 2016;173:807–815. doi: 10.1176/appi.ajp.2016.15040463
   Web of Science ®Google Scholar
• Hertzman M, Adler LW, Arling B, et al. Lisinopril may augment antidepressant response. J Clin Psychopharmacol. 2005;25:618–620. doi: 10.1097/01.jcp.0000186736.99523.1d
   PubMed Web of Science ®Google Scholar
• Girardin F, Sztajzel J. Cardiac adverse reactions associated with psychotropic drugs. Dialogues Clin Neurosci. 2007;9:92–95.
   Google Scholar